Finance

Beta
Lists
GANX:NASDAQ
Gain Therapeutics Inc
$1.70
-8.60%
(-0.16) 1D
Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
$1.84
High
$1.84
Low
$1.68
Mkt. cap
72.51M
Avg. vol.
623.93K
Volume
613.03K
52-wk high
$4.34
52-wk low
$1.41
EPS
-$0.60
Beta
0.16
Shares outstanding
42.65M
No. of employees
21
Open
$1.84
High
$1.84
Low
$1.68
Mkt. cap
72.51M
Avg. vol.
623.93K
Volume
613.03K
52-wk high
$4.34
52-wk low
$1.41
EPS
-$0.60
Beta
0.16
Shares outstanding
42.65M
No. of employees
21
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to GANX in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current $1.70
$8.00 (+370.59%)
Average
$7.20 (+323.53%)
Lowest
$5.00 (+194.12%)
News stories
From sources across the web
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorBiotechnology
Websitegaintherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
2.72M
2.81M
2.32M
-
Cost of revenue
2.72M
2.81M
2.32M
-
Research and development expenses
-
-
-
2.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.37M
1.98M
2.15M
2.59M
Operating expense
2.37M
1.98M
2.15M
5.35M
Total operating expenses
5.09M
4.79M
4.47M
5.35M
Operating income
-5.09M
-4.79M
-4.47M
-5.35M
Other non operating income
-
-
-
-
EBT including unusual items
-5.67M
-4.74M
-4.47M
-5.43M
EBT excluding unusual items
-5.67M
-4.74M
-4.47M
-5.43M
Income tax expense
141.20K
549.29K
70.12K
183.07K
Effective tax rate
-2.49%
-11.60%
-1.57%
-3.37%
Other operating expenses
-
-
-
-
Net income
-5.81M
-5.28M
-4.54M
-5.61M
Net profit margin
-
-
-
-
Earnings per share
-0.19
-0.15
-0.11
-0.13
Interest and investment income
47.64K
83.30K
88.58K
93.05K
Interest expense
-
-
-
-
Net interest expenses
47.64K
83.30K
88.58K
93.05K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.09M
-4.78M
-4.46M
-5.33M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer